Find Mebendazole manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

USP

0

JP

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

126RELATED EXCIPIENT COMPANIES

200EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

GLOBAL SALES INFORMATION

Annual Reports

NA

MARKET PLACE

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 31431-39-7, Vermox, Pantelmin, Telmin, Mebenvet, Ovitelmin
Molecular Formula
C16H13N3O3
Molecular Weight
295.29  g/mol
InChI Key
OPXLLQIJSORQAM-UHFFFAOYSA-N
FDA UNII
81G6I5V05I

Mebendazole
A benzimidazole that acts by interfering with CARBOHYDRATE METABOLISM and inhibiting polymerization of MICROTUBULES.
Mebendazole is an Anthelmintic.
1 2D Structure

Mebendazole

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
methyl N-(6-benzoyl-1H-benzimidazol-2-yl)carbamate
2.1.2 InChI
InChI=1S/C16H13N3O3/c1-22-16(21)19-15-17-12-8-7-11(9-13(12)18-15)14(20)10-5-3-2-4-6-10/h2-9H,1H3,(H2,17,18,19,21)
2.1.3 InChI Key
OPXLLQIJSORQAM-UHFFFAOYSA-N
2.1.4 Canonical SMILES
COC(=O)NC1=NC2=C(N1)C=C(C=C2)C(=O)C3=CC=CC=C3
2.2 Other Identifiers
2.2.1 UNII
81G6I5V05I
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Anti Worm

2. Anti-worm

3. Bantenol

4. Banworm

5. Boots Threadworm Treatment

6. Lomper

7. Madicure

8. Mebendan

9. Mebenvet

10. Pripsen Mebendazole

11. R17635

12. Sqworm

13. Sufil

14. Surfont

15. Telmin

16. Vermicol

17. Vermidil

18. Vermox

19. Wormkuur

2.3.2 Depositor-Supplied Synonyms

1. 31431-39-7

2. Vermox

3. Pantelmin

4. Telmin

5. Mebenvet

6. Ovitelmin

7. Vermicidin

8. Vermirax

9. Mebenoazole

10. Bantenol

11. Mebutar

12. Lomper

13. Mbdz

14. Besantin

15. Verpanyl

16. Noverme

17. Mebendazolum

18. Methyl (5-benzoyl-1h-benzo[d]imidazol-2-yl)carbamate

19. 5-benzoyl-2-benzimidazolecarbamic Acid Methyl Ester

20. Methyl 5-benzoyl-2-benzimidazolecarbamate

21. Carbamic Acid, (5-benzoyl-1h-benzimidazol-2-yl)-, Methyl Ester

22. Methyl 5-benzoyl-2-benzimidazolylcarbamate

23. R 17,635

24. Methyl N-(6-benzoyl-1h-benzimidazol-2-yl)carbamate

25. R 17635

26. Methyl (5-benzoyl-1h-benzimidazol-2-yl)carbamate

27. Methyl 5-benzoyl Benzimidazole-2-carbamate

28. (5-benzoyl-1h-benzimidazol-2-yl)-carbamic Acid Methyl Ester

29. Mfcd00057872

30. Methyl N-(5-benzoyl-1h-benzimidazol-2-yl)carbamate

31. Zhihuanqing

32. Ccris 4479

33. Methyl N-(6-benzoyl-1h-1,3-benzodiazol-2-yl)carbamate

34. Nsc 184849

35. 2-benzimidazolecarbamic Acid, 5-benzoyl-, Methyl Ester

36. Mebendazole Polymorph C

37. Mebendazol

38. Sufil

39. Chembl685

40. Nsc-184849

41. N-2 (5-benzoyl-benzimidazole) Carbamate De Methyle

42. N-(benzoyl-5, Benzimidazolyl)-2, Carbamate De Methyle

43. Chebi:6704

44. Carbamic Acid, N-(5-benzoylbenzimidazol-2-yl)-, Methyl Ester

45. Versid

46. Methyl 6-benzoyl-1h-benzimidazol-2-ylcarbamate

47. 81g6i5v05i

48. R-17635

49. 5-benzoyl-2-benzimidazolecarbamic Acid, Methyl Ester

50. Nsc184849

51. Methyl [5-(phenylcarbonyl)-1h-benzimidazol-2-yl]carbamate

52. Ncgc00016806-01

53. (5-benzoyl-1h-benzimidazol-2-yl)carbamic Acid Methyl Ester

54. Mebex

55. Cas-31431-39-7

56. Equivurm Plus

57. Dsstox_cid_20682

58. Dsstox_rid_79538

59. Dsstox_gsid_40682

60. Mebendazol [inn-spanish]

61. Mebendazolum [inn-latin]

62. Vermox (tn)

63. Emverm

64. Smr000036734

65. Hsdb 3232

66. Sr-01000003109

67. Einecs 250-635-4

68. Methyl N-(5-benzoyl-2-benzimidazolyl)carbamate

69. Mebatreat

70. Mebendazole (jan/usp/inn)

71. Unii-81g6i5v05i

72. Equivurmp Plus

73. N-2 (5-benzoyl-benzimidazole) Carbamate De Methyle [french]

74. Mebendazole,(s)

75. N-(benzoyl-5, Benzimidazolyl)-2, Carbamate De Methyle [french]

76. V95

77. Prestwick_310

78. Mebendazole; 4030

79. Mebendazole [usan:usp:inn:ban:jan]

80. Spectrum_001298

81. Cpd000036734

82. Prestwick0_000217

83. Prestwick1_000217

84. Prestwick2_000217

85. Prestwick3_000217

86. Spectrum2_001401

87. Spectrum3_001439

88. Spectrum4_000416

89. Spectrum5_001381

90. Mebendazole [inn]

91. Mebendazole [jan]

92. Mebendazole [hsdb]

93. Mebendazole [usan]

94. Probes1_000013

95. Probes2_000149

96. Mebendazole [vandf]

97. Cambridge Id 5250893

98. Methyl [5-(benzoyl)benzimidazol-2-yl]carbamate

99. Timtec1_000869

100. Mebendazole [mart.]

101. Oprea1_278237

102. Oprea1_768530

103. Schembl15860

104. Bspbio_000233

105. Bspbio_003178

106. Cbdive_010559

107. Kbiogr_000712

108. Kbioss_001778

109. Mebendazole [usp-rs]

110. Mebendazole [who-dd]

111. Mebendazole [who-ip]

112. Mls000028491

113. Mls006011879

114. Bidd:gt0087

115. Divk1c_000751

116. Mebendazolum [who-ip]

117. Spectrum1501110

118. Spbio_001442

119. Spbio_002154

120. Bpbio1_000257

121. Methyl N-[6-(benzoyl)-1h-benzimidazol-2-yl]carbamate

122. Dtxsid4040682

123. Mebendazole [green Book]

124. Hms502f13

125. Kbio1_000751

126. Kbio2_001778

127. Kbio2_004346

128. Kbio2_006914

129. Kbio3_002398

130. Mebendazole [orange Book]

131. Mebendazole For System Suitability

132. Ninds_000751

133. 2-benzimidazolecarbamic Acid, 5-benzoyl-, Methyl Ester (8ci)

134. Hms1536h11

135. Hms1568l15

136. Hms1921f03

137. Hms2090b03

138. Hms2092b15

139. Hms2095l15

140. Hms3259b11

141. Hms3604n11

142. Hms3712l15

143. Mebendazole [ep Monograph]

144. Mebendazole [usp Impurity]

145. Pharmakon1600-01501110

146. Zinc121541

147. Mebendazole [usp Monograph]

148. Tox21_110620

149. Bbl008298

150. Bdbm50180753

151. Ccg-39628

152. Mmv003152

153. Nsc757838

154. S4610

155. Stk093862

156. Akos000539066

157. Akos015896232

158. Carbamic Acid, (5-benzoyl-1h-benzimidazol-2-yl)-, Methyl Ester (9ci)

159. Tox21_110620_1

160. Cs-3974

161. Db00643

162. Mebendazole 100 Microg/ml In Methanol

163. Nc00639

164. Nsc-757838

165. Idi1_000751

166. Mebendazole Polymorph C [usp-rs]

167. Ncgc00016806-02

168. Ncgc00016806-03

169. Ncgc00016806-04

170. Ncgc00016806-05

171. Ncgc00016806-06

172. Ncgc00016806-07

173. Ncgc00016806-08

174. Ncgc00016806-09

175. Ncgc00016806-10

176. Ncgc00016806-12

177. Ncgc00016806-13

178. Ncgc00021698-03

179. Ncgc00021698-04

180. Ncgc00021698-05

181. Ncgc00021698-06

182. Ncgc00021698-07

183. Ac-12064

184. As-12272

185. Hy-17595

186. Sy051142

187. Sbi-0051641.p002

188. Ab00052203

189. Ft-0628179

190. Ft-0628180

191. M2273

192. En300-50844

193. D00368

194. D70118

195. 5-benzoyl-2-benzimidazolylcarbamicacidmethylester

196. Ab00052203-09

197. Ab00052203_10

198. Mebendazole, Vetranal(tm), Analytical Standard

199. 431m397

200. A820852

201. Ag-205/04588045

202. Mebendazole, Analytical Standard, >=98% (hplc)

203. Methyl (6-benzoyl-1h-benzimidazol-2-yl)carbamate

204. Q422194

205. Methyl 5-benzoyl-1h-benzo[d]imidazol-2-ylcarbamate

206. Sr-01000003109-2

207. Sr-01000003109-3

208. W-106901

209. Brd-k77987382-001-01-7

210. Brd-k77987382-001-06-6

211. Brd-k77987382-001-08-2

212. Sr-01000003109-10

213. Methyl N-(5-benzoyl-1h-1,3-benzimidazol-2-yl)carbamate

214. Z234895185

215. 5-benzoyl-1h-benzimidazol-2-yl Carbamic Acid Methyl Ester;

216. Mebendazole, European Pharmacopoeia (ep) Reference Standard

217. Mebendazole, United States Pharmacopeia (usp) Reference Standard

218. Mebendazole For System Suitability, European Pharmacopoeia (ep) Reference Standard

219. Mebendazole Polymorph C, United States Pharmacopeia (usp) Reference Standard

2.4 Create Date
2005-03-25
3 Chemical and Physical Properties
Molecular Weight 295.29 g/mol
Molecular Formula C16H13N3O3
XLogP32.8
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count4
Rotatable Bond Count4
Exact Mass295.09569129 g/mol
Monoisotopic Mass295.09569129 g/mol
Topological Polar Surface Area84.1 Ų
Heavy Atom Count22
Formal Charge0
Complexity423
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Information
1 of 2  
Drug NameMebendazole
PubMed HealthMebendazole (By mouth)
Drug ClassesAnthelmintic
Drug LabelMebendazole is a (synthetic) broad-spectrum anthelmintic available as chewable tablets, each containing 100 mg of mebendazole. Inactive ingredients are: anhydrous lactose NF, corn starch, magnesium stearate, microcrystalline cellulose, sodium lauryl...
Active IngredientMebendazole
Dosage FormTablet, chewable
RouteOral
Strength100mg
Market StatusPrescription
CompanyAmedra Pharms

2 of 2  
Drug NameMebendazole
PubMed HealthMebendazole (By mouth)
Drug ClassesAnthelmintic
Drug LabelMebendazole is a (synthetic) broad-spectrum anthelmintic available as chewable tablets, each containing 100 mg of mebendazole. Inactive ingredients are: anhydrous lactose NF, corn starch, magnesium stearate, microcrystalline cellulose, sodium lauryl...
Active IngredientMebendazole
Dosage FormTablet, chewable
RouteOral
Strength100mg
Market StatusPrescription
CompanyAmedra Pharms

4.2 Therapeutic Uses

Mesh Heading: Antinematodal agents

National Library of Medicine, SIS; ChemIDplus Record for Mebendazole (31431-39-7). Available from, as of April 17, 2006: https://chem.sis.nlm.nih.gov/chemidplus/chemidlite.jsp


Mebendazole is indicated as a primary agent for tichuriasis caused by Trichuris trichiura (whipworm). /Included in US product labeling/

Thomson/Micromedex. Drug Information for the Health Care Professional. Volume 1, Greenwood Village, CO. 2006., p. 1992


Mebendazole is indicated in the treatment of multiple intestinal roundworm infections. /Included in US product labeling/

Thomson/Micromedex. Drug Information for the Health Care Professional. Volume 1, Greenwood Village, CO. 2006., p. 1992


Mebendazole is indicated a a primary agent for enterobiasis caused by Enterobius vermicularis (pinworm). /Included in US product labeling/

Thomson/Micromedex. Drug Information for the Health Care Professional. Volume 1, Greenwood Village, CO. 2006., p. 1992


For more Therapeutic Uses (Complete) data for MEBENDAZOLE (19 total), please visit the HSDB record page.


4.3 Drug Warning

Organ system function (including hematopoietic and hepatic) should be assessed periodically during prolonged mebendazole therapy.

McEvoy, G.K. (ed.). American Hospital Formulary Service. AHFS Drug Information. American Society of Health-System Pharmacists, Bethesda, MD. 2006., p. 53


Other adverse effects reported rarely in patients receiving mebendazole include alopecia, rash, pruritus, urticaria, angioedema, flushing, hiccups, cough, weakness,drowsiness, chills, hypotension, seizures, transient abnormalities in liver function tests (e.g., increased serum concentrations of aminotransferases, alkaline phosphatase, and/or bilirubin), hepatitis, increased BUN, decreased hemoglobin concentration and/or hematocrit, leukopenia, thrombocytopenia, eosinophilia, hematuria, and cylindruria.Migration of roundworms through the mouth and nose also has been reported.

McEvoy, G.K. (ed.). American Hospital Formulary Service. AHFS Drug Information. American Society of Health-System Pharmacists, Bethesda, MD. 2006., p. 53


Myelosuppression manifested as neutropenia (including agranulocytosis) and/or thrombocytopenia also has been reported in patients receiving high-dose (e.g., 30-50 mg/kg daily) mebendazole therapy for extraintestinal infections; while the myelosuppression usually was reversible following discontinuance of the drug, death has occurred rarely.

McEvoy, G.K. (ed.). American Hospital Formulary Service. AHFS Drug Information. American Society of Health-System Pharmacists, Bethesda, MD. 2006., p. 53


At usual recommended dosages (i.e., 100-200 mg daily), mebendazole appears to cause minimal adverse effects. Adverse effects appear to occur more frequently when higher dosages (e.g., those used in the treatment of extraintestinal infections such as hydatid disease) are used, and may be related to effects resulting from drug-induced killing of the parasites in some cases. Transient diarrhea and abdominal pain have occurred occasionally during mebendazole treatment, but usually have been associated with massive infections and expulsion of the helminths. Nausea, vomiting, headache, tinnitus, numbness, and dizziness also have been reported occasionally during mebendazole therapy. Fever has occurred in some patients, particularly in those receiving high-dose therapy for extraintestinal infections.

McEvoy, G.K. (ed.). American Hospital Formulary Service. AHFS Drug Information. American Society of Health-System Pharmacists, Bethesda, MD. 2006., p. 53


For more Drug Warnings (Complete) data for MEBENDAZOLE (9 total), please visit the HSDB record page.


4.4 Drug Indication

For the treatment of Enterobius vermicularis (pinworm), Trichuris trichiura (whipworm), Ascaris lumbricoides (common roundworm), Ancylostoma duodenale (common hookworm), Necator americanus (American hookworm) in single or mixed infections.


5 Pharmacology and Biochemistry
5.1 Pharmacology

Mebendazole is a (synthetic) broad-spectrum anthelmintic. The principal mode of action for Mebendazole is by its inhibitory effect on tubulin polymerization which results in the loss of cytoplasmic microtubules.


5.2 MeSH Pharmacological Classification

Antinematodal Agents

Substances used in the treatment or control of nematode infestations. They are used also in veterinary practice. (See all compounds classified as Antinematodal Agents.)


Tubulin Modulators

Agents that interact with TUBULIN to inhibit or promote polymerization of MICROTUBULES. (See all compounds classified as Tubulin Modulators.)


5.3 FDA Pharmacological Classification
5.3.1 Active Moiety
MEBENDAZOLE
5.3.2 FDA UNII
81G6I5V05I
5.3.3 Pharmacological Classes
Anthelmintic [EPC]
5.4 ATC Code

P02CA01

S76 | LUXPHARMA | Pharmaceuticals Marketed in Luxembourg | Pharmaceuticals marketed in Luxembourg, as published by d'Gesondheetskeess (CNS, la caisse nationale de sante, www.cns.lu), mapped by name to structures using CompTox by R. Singh et al. (in prep.). List downloaded from https://cns.public.lu/en/legislations/textes-coordonnes/liste-med-comm.html. Dataset DOI:10.5281/zenodo.4587355


P - Antiparasitic products, insecticides and repellents

P02 - Anthelmintics

P02C - Antinematodal agents

P02CA - Benzimidazole derivatives

P02CA01 - Mebendazole


5.5 Absorption, Distribution and Excretion

Absorption

Poorly absorbed (approximately 5 to 10%) from gastrointestinal tract. Fatty food increases absorption.


Route of Elimination

In man, approximately 2% of administered mebendazole is excreted in urine and the remainder in the feces as unchanged drug or a primary metabolite.


Elimination: Fecal: Approximately 95% excreted unchanged or as the primary metabolite (2-amino derivative) in feces. Renal: Approximately 2 to 5% excreted unchanged or as the primary metabolite in urine.

Thomson/Micromedex. Drug Information for the Health Care Professional. Volume 1, Greenwood Village, CO. 2006., p. 1993


Peak serum concentration: Following a dose of 100 mg twice a day for 3 days: Mebendazole: Not more than 0.03 ug/mL. 2-Amino metabolite: Not more than 0.09 ug/mL. Serum concentrations up to 0.5 ug/mL have been reported in chronic, high-dose therapy.

Thomson/Micromedex. Drug Information for the Health Care Professional. Volume 1, Greenwood Village, CO. 2006., p. 1993


Time to peak serum concentration: 2 to 5 hours (range: 0.5 to 7 hours).

Thomson/Micromedex. Drug Information for the Health Care Professional. Volume 1, Greenwood Village, CO. 2006., p. 1993


Mebendazole is highly bound to plasma proteins. It is not known if mebendazole is distributed into milk.

McEvoy, G.K. (ed.). American Hospital Formulary Service. AHFS Drug Information. American Society of Health-System Pharmacists, Bethesda, MD. 2006., p. 53


For more Absorption, Distribution and Excretion (Complete) data for MEBENDAZOLE (11 total), please visit the HSDB record page.


5.6 Metabolism/Metabolites

Primarily hepatic. Primary metabolite is 2-amino-5-benzoylbenzimidazole, but also metabolized to inactive hydroxy and hydroxyamino metabolites. All metabolites are devoid of anthelmintic activity.


Primarily hepatic; metabolized in inactive amino, hydroxy, and hydroxyamino metabolites; primary metabolite is 2-amino-5-benzoylbenzimidazole.

Thomson/Micromedex. Drug Information for the Health Care Professional. Volume 1, Greenwood Village, CO. 2006., p. 1993


Although the exact metabolic fate of mebendazole has not been fully determined, the drug is metabolized via decarboxylation to 2-amino-5(6)-benzimidazolyl phenylketone; this metabolite does not have anthelmintic activity.

McEvoy, G.K. (ed.). American Hospital Formulary Service. AHFS Drug Information. American Society of Health-System Pharmacists, Bethesda, MD. 2006., p. 53


Mebendazole ... is extensively metabolized. Two major metabolites, methyl-5-(alpha-5-hydroxybenzyl)-2-benzimidazole carbamate and 2-amino-5-benzoylbenzimidazole, have lower rates of clearance than does mebendazole itself. Mebendazole, rather than its metabolites, appears to be the active drug form. Conjugates of mebendazole and its metabolites have been found in bile, but little unchanged mebendazole appears in the urine.

Hardman, J.G., L.E. Limbird, P.B., A.G. Gilman. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 10th ed. New York, NY: McGraw-Hill, 2001., p. 1126


5.7 Biological Half-Life

2.5 to 5.5 hours (range 2.5 to 9 hours) in patients with normal hepatic function. Approximately 35 hours in patients with impaired hepatic function (cholestasis).


Normal hepatic function: 2.5 to 5.5 hours (range: 2.5 to 9 hours). Impaired hepatic function (cholestasis): Approximately 35 hours.

Thomson/Micromedex. Drug Information for the Health Care Professional. Volume 1, Greenwood Village, CO. 2006., p. 1993


The elimination half-life of mebendazole has been reported to be about 2.8-9 hours.

McEvoy, G.K. (ed.). American Hospital Formulary Service. AHFS Drug Information. American Society of Health-System Pharmacists, Bethesda, MD. 2006., p. 53


5.8 Mechanism of Action

Mebendazole causes degenerative alterations in the tegument and intestinal cells of the worm by binding to the colchicine-sensitive site of tubulin, thus inhibiting its polymerization or assembly into microtubules. The loss of the cytoplasmic microtubules leads to impaired uptake of glucose by the larval and adult stages of the susceptible parasites, and depletes their glycogen stores. Degenerative changes in the endoplasmic reticulum, the mitochondria of the germinal layer, and the subsequent release of lysosomes result in decreased production of adenosine triphosphate (ATP), which is the energy required for the survival of the helminth. Due to diminished energy production, the parasite is immobilized and eventually dies.


Although the exact mechanism of anthelmintic activity of mebendazole has not been fully elucidated, the drug appears to cause selective and irreversible inhibition of the uptake of glucose and other low molecular weight nutrients in susceptible helminths; inhibition of glucose uptake appears to result in endogenous depletion of glycogen stores in the helminth. Mebendazole does not inhibit glucose uptake in mammals. Mebendazole appears to cause degenerative changes in the intestine of nematodes and in the absorptive cells of cestodes. The principal anthelmintic effect of the drug appears to be degeneration of cytoplasmic microtubules within these intestinal and absorptive cells. Microtubular deterioration results in inhibition of organelle movement and interferes with the absorptive and secretory function. As a result of excessive accumulation of intracellular transport secretory granules, hydrolytic and proteolytic enzymes are released and cause cellular autolysis. This irreversible damage leads to death of the parasite.

McEvoy, G.K. (ed.). American Hospital Formulary Service. AHFS Drug Information. American Society of Health-System Pharmacists, Bethesda, MD. 2006., p. 53


Vermicidal; may also be ovicidal for ova or most helminths; mebendazole causes degeneration of parasite's cytoplasmic microtubules and thereby selectively and irreversibly blocks glucose uptake in susceptible adult intestine-dwelling helminths and their tissue-dwelling larvae; inhibition of glucose uptake apparently results in depletion of the parasite's glycogen stores; this, in turn, results in reduced formation of adenosine triphosphate (ATP) required for survival and reproduction of the helminth; corresponding energy levels are gradually reduced until death of the parasite ensues; mebendazole does not appear to affect serum glucose concentrations in humans, however.

Thomson/Micromedex. Drug Information for the Health Care Professional. Volume 1, Greenwood Village, CO. 2006., p. 1993


Benzimidazoles produce many biochemical changes in susceptible nematodes, eg, inhibition of mitochondrial fumarate reductase, reduced glucose transport, and uncoupling of oxidative phosphorylation ... /but/ the primary action ... /should be/ to inhibit microtubule polymerization by binding to beta-tubulin. The selective toxicity of these agents derives from the fact that specific, high-affinity binding to parasite beta-tubulin occurs at much lower concn than does binding to the mammalian protein ... Benzimidazole-resistant Haemonchus contortus display reduced high-affinity drug binding to beta-tubulin and alterations in beta-tubulin isotype gene expression that correlate with drug resistance ... Two identified mechanisms of drug resistance in nematodes involve both a progressive loss of "susceptible" beta-tubulin gene isotypes together with emergence of a "resistant" isotype with a conserved point mutation that encodes a tyrosine instead of phenylalanine at position 200 of beta-tubulin. While this mutation may not be required for benzimidazole resistance in all parasites, eg, Giardia lamblia, benzimidazole resistance in parasitic nematodes is unlikely to be overcome by novel benzimidazole analogs, because tyrosine also is present at position 200 of human beta-tubulin. /Benzimidazoles/

Hardman, J.G., L.E. Limbird, P.B., A.G. Gilman. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 10th ed. New York, NY: McGraw-Hill, 2001., p. 1126


Listed Suppliers

read-more
read-more

01

Suanfarma

Spain
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSuanfarma, at the Core of a Better Life.

Flag Spain
Digital Content Digital Content

Mebendazole

About the Company : Suanfarma is a B2B life sciences company focused on developing, manufacturing, and distributing high-quality ingredients for the pharmaceutical industry in an innovative and sustai...

Suanfarma is a B2B life sciences company focused on developing, manufacturing, and distributing high-quality ingredients for the pharmaceutical industry in an innovative and sustainable way. With 10 global offices, it serves over 400 customers in 70+ countries. Suanfarma collaborates closely with clients on final formulations, delivering customized solutions and adding value throughout the drug development process. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Suanfarma

02

LGM Pharma

U.S.A
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothLGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Flag U.S.A
Digital Content Digital Content

Mebendazole

About the Company : LGM Pharma is a global leader in sourcing APIs, including hard-to-find drug substances, for pharmaceutical and biotech industries. LGM also operates as a full-service drug product ...

LGM Pharma is a global leader in sourcing APIs, including hard-to-find drug substances, for pharmaceutical and biotech industries. LGM also operates as a full-service drug product CDMO, offering formulation, analytical method development and testing, regulatory support, and commercial manufacturing. Supported by a network of over 220 accredited cGMP manufacturing partners and more than 100,000 sq. ft. of FDA-inspected cGMP manufacturing and warehouse space, LGM delivers secure, end-to-end solutions across multiple dosage forms. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
LGM Pharma CB

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothJai Radhe Sales is your partner for all your sourcing needs.

Flag India
Digital Content Digital Content

Mebendazole

About the Company : Jai Radhe Sales, founded in 1999, is a global distributor specializing in high-quality pharmaceutical ingredients from India. It offers complete sourcing solutions, technical and r...

Jai Radhe Sales, founded in 1999, is a global distributor specializing in high-quality pharmaceutical ingredients from India. It offers complete sourcing solutions, technical and regulatory support, and strives for global standards. Known for quality and affordability, it has established a niche through innovative methods and exports to nearly every continent. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Jai Radhe Sales

04

HRV Pharma

India
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothHRV Pharma - Market Expansion Leader in Pharmaceuticals.

Flag India
Digital Content Digital Content

Mebendazole

About the Company : HRV Pharma is a global manufacturer, seller, and exporter of APIs, intermediates, pellets, food-grade chemicals, food additives, and food ingredients. The company provides sourcing...

HRV Pharma is a global manufacturer, seller, and exporter of APIs, intermediates, pellets, food-grade chemicals, food additives, and food ingredients. The company provides sourcing, manufacturing, and supply services to support partners entering new markets worldwide. HRV Pharma works closely with major pharma and food additive companies and represents over 30 Indian drugmakers, primarily serving Europe, the US, and the Middle East. Headquartered in India, it operates offices in the US, Switzerland, Dubai, Lithuania, and Turkey. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
HRV Global Life Sciences

05

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTenatra connects Indian manufacturers with global buyers through active partners in Germany, Switzerland, Belgium, Spain & Turkey.

Flag India
Digital Content Digital Content

Mebendazole

About the Company : Tenatra International was established as a proprietorship firm in 1999. It got off to a very good start, supporting clients in the United States, Mexico and Europe. As business opp...

Tenatra International was established as a proprietorship firm in 1999. It got off to a very good start, supporting clients in the United States, Mexico and Europe. As business opportunities grew, it was felt that the proprietorship firm had outlived its usefulness and that it needed a corporate structure. So, Tenatra Exports Private Limited was incorporated in 2002. Since then, the company has come a long way, gaining valuable experience and knowledge in the fields of chemicals and pharmaceuticals in India. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Tenatra

06

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

Flag India
Digital Content Digital Content

Mebendazole

About the Company : Swati Spentose Pvt. Ltd. (SSPL), part of the 60-year-old V Group, is a globally trusted pharmaceutical manufacturer supplying to 70+ countries. We specialize in high-quality APIs a...

Swati Spentose Pvt. Ltd. (SSPL), part of the 60-year-old V Group, is a globally trusted pharmaceutical manufacturer supplying to 70+ countries. We specialize in high-quality APIs and are forward-integrated into Finished Dosage Forms, offering end-to-end solutions. SSPL Unit 1 is USFDA inspected, EU-GMP, ANVISA, WHO-GMP, COFEPRIS, MFDS certified, AFM: AG12300239. SSPL Unit 2 is PMDA inspected and WHO-GMP, ANVISA certified. We look forward to exploring collaboration opportunities. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Company Banner

07

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

Flag India
Digital Content Digital Content

Mebendazole

About the Company : Swati Spentose Pvt. Ltd. (SSPL), part of the 60-year-old V Group, is a globally trusted pharmaceutical manufacturer supplying to 70+ countries. We specialize in high-quality APIs a...

Swati Spentose Pvt. Ltd. (SSPL), part of the 60-year-old V Group, is a globally trusted pharmaceutical manufacturer supplying to 70+ countries. We specialize in high-quality APIs and are forward-integrated into Finished Dosage Forms, offering end-to-end solutions. SSPL Unit 1 is USFDA inspected, EU-GMP, ANVISA, WHO-GMP, COFEPRIS, MFDS certified, AFM: AG12300239. SSPL Unit 2 is PMDA inspected and WHO-GMP, ANVISA certified. We look forward to exploring collaboration opportunities. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Company Banner

08

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothWillow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

Flag U.S.A
Digital Content Digital Content

Mebendazole

About the Company : Willow Birch Pharma, Inc. is a premier supplier of bulk APIs to North American Compounding Pharmacies, sourcing from FDA registered and GMP manufacturers. With licenses in all 50 s...

Willow Birch Pharma, Inc. is a premier supplier of bulk APIs to North American Compounding Pharmacies, sourcing from FDA registered and GMP manufacturers. With licenses in all 50 states as a drug wholesaler and NABP accreditation since 2007, Willow Birch Pharma delivers top-quality products at competitive prices with unparalleled service and regulatory support nationwide. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Company Banner

09

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Mebendazole

About the Company : At APPL, we are committed to formulating and providing healthcare products, to an increasingly quality-determined world, at competitive yet affordable prices. Upholding the princip...

At APPL, we are committed to formulating and providing healthcare products, to an increasingly quality-determined world, at competitive yet affordable prices. Upholding the principles of quality in all aspects of our business, and better business practices are the main ideals governing corporate operations at APPL, to enter into the manufacturing, marketing and distribution of pharmaceutical products. From a moderate yet disciplined beginning, the strategic creation of APPL has resulted in much success, and through our sincere approach and conscientious ingenuity, we have risen to be a reputable organisation.
blank

10

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Mebendazole

About the Company : Hebei Veyong Pharmaceutical Co., Ltd, was established in 2002 and located in Economic and Technological Development Zone in Shijiazhuang. It is a large veterinary enterprise with G...

Hebei Veyong Pharmaceutical Co., Ltd, was established in 2002 and located in Economic and Technological Development Zone in Shijiazhuang. It is a large veterinary enterprise with GMP certificate in China with research and development, production and sales of veterinary API and preparations. It is national high-tech enterprise, Hebei famous trademark enterprise, the vice-chairman company of Hebei Association of Animal Science and Veterinary Medicine, the vice-chairman company of Hebei Animal Health Products Association.
blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Europe

read-more
read-more

01

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Mebendazole

Brand Name : Vermox

Dosage Form : Tablet

Dosage Strength : 100mg

Packaging :

Approval Date : 14-05-2024

Application Number : 28107132124

Regulatory Info : Prescription

Registration Country : Denmark

blank

02

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Mebendazole

Brand Name : Vermox

Dosage Form : Tablet

Dosage Strength : 100mg

Packaging :

Approval Date : 26-01-2021

Application Number : 2.02E+13

Regulatory Info : Approved

Registration Country : Sweden

blank

03

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Mebendazol

Brand Name : Lomper

Dosage Form : Tablet

Dosage Strength : 100MG

Packaging :

Approval Date : 01-05-1973

Application Number : 51200

Regulatory Info : Authorized

Registration Country : Spain

blank

04

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Mebendazole

Brand Name : Vermox

Dosage Form : Tablet

Dosage Strength : 100mg

Packaging :

Approval Date : 29-10-2018

Application Number :

Regulatory Info :

Registration Country : Moldova

blank

05

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Mebendazole

Brand Name : Vermox

Dosage Form : Mebendazole 100Mg 6 Combined Oral Use

Dosage Strength : 6 CPR 100 mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

06

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Mebendazole

Brand Name : Vermox

Dosage Form : Mebendazole 500Mg 30 Joined' Oral Use

Dosage Strength : 30 CPR 500 mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

07

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Mebendazole

Brand Name : Vermox

Dosage Form : Tablet

Dosage Strength : 100MG

Packaging :

Approval Date : 2007-01-30

Application Number :

Regulatory Info : Authorised

Registration Country : Malta

blank

08

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Mebendazole

Brand Name : Vermox

Dosage Form : Oral Suspension

Dosage Strength : 20mg/ml

Packaging :

Approval Date : 28-05-1980

Application Number : 28100993478

Regulatory Info : Prescription

Registration Country : Denmark

blank

09

Orifarm A/S

Denmark
AACR Annual meeting
Not Confirmed
arrow

Orifarm A/S

Denmark
arrow
AACR Annual meeting
Not Confirmed

Mebendazole

Brand Name : Vermox

Dosage Form : Tablet

Dosage Strength : 100mg

Packaging :

Approval Date : 22-01-2015

Application Number : 28105519414

Regulatory Info : Prescription

Registration Country : Denmark

blank

10

Orifarm Ab

Denmark
AACR Annual meeting
Not Confirmed
arrow

Orifarm Ab

Denmark
arrow
AACR Annual meeting
Not Confirmed

Mebendazole

Brand Name : Vermox

Dosage Form : Tablet

Dosage Strength : 100mg

Packaging :

Approval Date : 29-04-2013

Application Number : 2.01E+13

Regulatory Info : Deregistered

Registration Country : Sweden

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Canada

read-more
read-more

01

JANSSEN INC

U.S.A
AACR Annual meeting
Not Confirmed
arrow

JANSSEN INC

U.S.A
arrow
AACR Annual meeting
Not Confirmed

MEBENDAZOLE

Brand Name : VERMOX

Dosage Form : TABLET

Dosage Strength : 100MG

Packaging : 6

Approval Date :

Application Number : 556734

Regulatory Info : PRESCRIPTION

Registration Country : Canada

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Fillers, Diluents & Binders

read-more
read-more

Direct Compression

read-more
read-more

Granulation

read-more
read-more

Lubricants & Glidants

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Co-Processed Excipients

read-more
read-more

Taste Masking

read-more
read-more

Coating Systems & Additives

read-more
read-more

Controlled & Modified Release

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

Solubilizers

read-more
read-more

Emulsifying Agents

read-more
read-more

Parenteral

read-more
read-more

Topical

read-more
read-more

Rheology Modifiers

read-more
read-more

API Stability Enhancers

read-more
read-more

Surfactant & Foaming Agents

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ANALYTICAL

Upload your methods for free, ask us

ABOUT THIS PAGE

Looking for 31431-39-7 / Mebendazole API manufacturers, exporters & distributors?

Mebendazole manufacturers, exporters & distributors 1

46

PharmaCompass offers a list of Mebendazole API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Mebendazole manufacturer or Mebendazole supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Mebendazole manufacturer or Mebendazole supplier.

API | Excipient name

Mebendazole

Synonyms

31431-39-7, Vermox, Pantelmin, Telmin, Mebenvet, Ovitelmin

Cas Number

31431-39-7

Unique Ingredient Identifier (UNII)

81G6I5V05I

About Mebendazole

A benzimidazole that acts by interfering with CARBOHYDRATE METABOLISM and inhibiting polymerization of MICROTUBULES.

MBDZ Manufacturers

A MBDZ manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of MBDZ, including repackagers and relabelers. The FDA regulates MBDZ manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. MBDZ API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of MBDZ manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.

MBDZ Suppliers

A MBDZ supplier is an individual or a company that provides MBDZ active pharmaceutical ingredient (API) or MBDZ finished formulations upon request. The MBDZ suppliers may include MBDZ API manufacturers, exporters, distributors and traders.

click here to find a list of MBDZ suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.

MBDZ USDMF

A MBDZ DMF (Drug Master File) is a document detailing the whole manufacturing process of MBDZ active pharmaceutical ingredient (API) in detail. Different forms of MBDZ DMFs exist exist since differing nations have different regulations, such as MBDZ USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A MBDZ DMF submitted to regulatory agencies in the US is known as a USDMF. MBDZ USDMF includes data on MBDZ's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The MBDZ USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of MBDZ suppliers with USDMF on PharmaCompass.

MBDZ CEP

A MBDZ CEP of the European Pharmacopoeia monograph is often referred to as a MBDZ Certificate of Suitability (COS). The purpose of a MBDZ CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of MBDZ EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of MBDZ to their clients by showing that a MBDZ CEP has been issued for it. The manufacturer submits a MBDZ CEP (COS) as part of the market authorization procedure, and it takes on the role of a MBDZ CEP holder for the record. Additionally, the data presented in the MBDZ CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the MBDZ DMF.

A MBDZ CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. MBDZ CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.

click here to find a list of MBDZ suppliers with CEP (COS) on PharmaCompass.

MBDZ WC

A MBDZ written confirmation (MBDZ WC) is an official document issued by a regulatory agency to a MBDZ manufacturer, verifying that the manufacturing facility of a MBDZ active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting MBDZ APIs or MBDZ finished pharmaceutical products to another nation, regulatory agencies frequently require a MBDZ WC (written confirmation) as part of the regulatory process.

click here to find a list of MBDZ suppliers with Written Confirmation (WC) on PharmaCompass.

MBDZ NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing MBDZ as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for MBDZ API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture MBDZ as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain MBDZ and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a MBDZ NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of MBDZ suppliers with NDC on PharmaCompass.

MBDZ GMP

MBDZ Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of MBDZ GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right MBDZ GMP manufacturer or MBDZ GMP API supplier for your needs.

MBDZ CoA

A MBDZ CoA (Certificate of Analysis) is a formal document that attests to MBDZ's compliance with MBDZ specifications and serves as a tool for batch-level quality control.

MBDZ CoA mostly includes findings from lab analyses of a specific batch. For each MBDZ CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

MBDZ may be tested according to a variety of international standards, such as European Pharmacopoeia (MBDZ EP), MBDZ JP (Japanese Pharmacopeia) and the US Pharmacopoeia (MBDZ USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty